Both also contained OMV, one from the Norwegian ... Canada Neisseria meningitidisserogroup B (MenB) invasive meningococcal disease is a rare disease in Canada. MenB vaccines are unique in terms ...

Also active in the category is Sanofi, which sells MenACWY vaccines Menactra and MenQuadfi, lacking coverage of the B serogroup considered the most common cause of meningococcal disease in the US.

Hundreds have already taken advantage of the CLP’s free meningococcal B vaccination program, which provides protection for infants aged six weeks to two years, and teens aged 14 to 19 years.